Clinical bottom line
Cannabis use is increasingly common among surgical patients, necessitating anesthesiologists’ awareness of its potential effects on anesthetic management. Current evidence suggests that chronic cannabis users may require higher doses of certain anesthetic agents such as propofol, experience altered pain perception, and have variable responses to opioids. However, standardized guidelines remain limited, and perioperative care should be individualized, considering patient age, cannabis use patterns, and comorbidities. Preoperative screening and multidisciplinary planning are essential to optimize anesthesia safety and efficacy in this population (Ahrens et al., 2024; Sajdeya et al., 2025).
What the evidence shows
Ahrens et al. (2024) highlight that older adults using cannabis may exhibit altered pharmacodynamics, with potential increased anesthetic requirements and cardiovascular effects necessitating careful intraoperative monitoring.
Sajdeya et al. (2025) review recent insights into cannabis interactions with propofol anesthesia, noting that chronic cannabis use may increase propofol dose requirements and affect emergence times, although data are heterogeneous.
Mann et al. (2026) report that outpatient anesthesia in cannabis users can be complicated by increased perioperative pain and opioid consumption, suggesting altered nociception and tolerance mechanisms.
Davidson et al. (2020) discuss anesthetic considerations in medical cannabis patients, emphasizing the importance of detailed history-taking and awareness of cannabis-related respiratory, cardiovascular, and neurocognitive effects.
Kitzman et al. (2024) address perioperative considerations in adolescents and young adults with substance use disorders, including cannabis, underscoring the need for tailored pain management and monitoring strategies.
Wolinsky et al. (2023) provide an overview of pharmacologic interventions for cannabis withdrawal syndrome, relevant for perioperative management in dependent patients.
Caveats and uncertainty
Most evidence is observational or derived from small cohorts, limiting generalizability.
Variability in cannabis formulations, dosing, and routes of administration complicates interpretation.
Potential interactions with anesthetic agents are incompletely characterized.
Lack of standardized protocols for perioperative cannabis management persists.
Withdrawal symptoms and their impact on anesthesia remain understudied.
How this may change practice
Preoperative assessment should include detailed cannabis use history, including frequency, dose, and last use.
Anesthesia plans may require adjustment of induction and maintenance agent dosages, particularly propofol and opioids.
Enhanced intraoperative monitoring for cardiovascular and respiratory effects is advisable.
Multidisciplinary collaboration with pain specialists and addiction medicine may improve perioperative outcomes.
Patient education regarding potential anesthesia-related risks associated with cannabis use is important.
Development of institutional guidelines and further research will support evidence-based practice.